Moreover, the number of reported serous endometrial cancer cases are small, confidence intervals wide, and the absolute lifetime risk is low (around 3%), and total endometrial cancer risk is not increased in BRCA1 carriers. Here, BRCA1 is linked to endometrial cancer.